Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127763051 | 12776305 | 1 | I | 20160916 | 20160923 | 20160923 | EXP | JP-ABBVIE-16P-087-1732365-00 | ABBVIE | 0.00 | N | M | Y | 2.37000 | KG | 20160923 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127763051 | 12776305 | 1 | PS | KALETRA | LOPINAVIRRITONAVIR | 1 | Transplacental | U | UNKNOWN | 21906 | TABLET | ||||||||
| 127763051 | 12776305 | 2 | C | RITODRINE HYDROCHLORIDE | RITODRINE HYDROCHLORIDE | 1 | Transplacental | 50 MCG/MIN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127763051 | 12776305 | 1 | Maternal exposure timing unspecified |
| 127763051 | 12776305 | 2 | Maternal exposure timing unspecified |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127763051 | 12776305 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127763051 | 12776305 | Foetal exposure during pregnancy | |
| 127763051 | 12776305 | Hypocalcaemia | |
| 127763051 | 12776305 | Low birth weight baby | |
| 127763051 | 12776305 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |